Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Waldenstrom Macroglobulinemia 1Urogenital Neoplasms 1Ulnar Neuropathies 1Thrombocythemia, Essential 1Sezary Syndrome 1Rectal Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Nurse-Patient Relations 1Neuroma 1Neoplasms 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Mycosis Fungoides 1Multiple Myeloma 1Motor Activity 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Magnetic Resonance Spectroscopy 14Temozolomide 10Specimen Handling 10X-Rays 8Radiotherapy 7Biopsy 7Phantoms, Imaging 6Nuclear Medicine Department, Hospital 6trametinib 4ulixertinib 3olaparib 3larotrectinib 3erdafitinib 3dabrafenib 3Radiotherapy, Intensity-Modulated 3Nivolumab 3tipifarnib 2selpercatinib 2pembrolizumab 2palbociclib 2niraparib 2ivosidenib 2ensartinib 2atezolizumab 2abemaciclib 2Surveys and Questionnaires 2Radiation 2Proton Therapy 2Lomustine 2Irinotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Glioma × Therapeutics × Clear all
NCT05406700 2026-02-09

Niraparib In Recurrent IDH 1/2 Gliomas

Massachusetts General Hospital

Phase EARLY_PHASE1 Active not recruiting
16 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡